Correlation between CH2DS2-VASc Score and Serum Leptin Levels in Cardioembolic Stroke Patients: The Impact of Metabolic Syndrome

المؤلفون المشاركون

Rejdak, Konrad
Kurzepa, Jacek
Bielewicz, Joanna
Szczepańska-Szerej, Anna
Grabarska, Aneta
Wlizło-Dyś, Ewa

المصدر

International Journal of Endocrinology

العدد

المجلد 2017، العدد 2017 (31 ديسمبر/كانون الأول 2017)، ص ص. 1-10، 10ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2017-10-31

دولة النشر

مصر

عدد الصفحات

10

التخصصات الرئيسية

الأحياء

الملخص EN

Objective.

To determine adipokines levels in patients with different etiologic subtypes of acute ischemic stroke (AIS) and metabolic syndrome (MetS) status.

Methods.

Serum adiponectin, leptin, and resistin levels were determined by ELISA in 99 AIS patients and 59 stroke-free control group subjects.

Stroke patients were grouped based on MetS, modified TOAST classification, and CHA2DS2-VASc scale in case of cardioembolic stroke following atrial fibrillation.

Results.

No differences were found in all adipokine serum levels between AIS patients and appropriately matched control group.

MetS-AIS patients had significantly higher leptin levels (22.71 ± 19.01 ng/ml versus 8.95 ± 9.22 ng/ml, p<0.001) and lower adiponectin levels (10.71 ± 8.59 ng/ml versus 14.93 ± 10.95 ng/ml, p<0.05) than non-MetS-AIS patients.

In patients with cardioembolic stroke, leptin levels were significantly higher than in remaining stroke cases (19.57 ± 20.53 ng/ml versus 13.17 ± 12.36 ng/ml, p<0.05) and CHA2DS2-VASc score positively correlated with leptin levels only (p<0.001).

Analysis of individual components of CHA2DS2-VASc score showed that hypertension, female gender, and diabetes had greatest impact on elevated serum leptin level.

Conclusion.

This pilot study revealed that leptin could be a potential biomarker for risk stratification of cardioembolic stroke in MetS patients and that heterogeneity of stroke subtypes should be considered for more refined and precise clinical stroke studies.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Szczepańska-Szerej, Anna& Kurzepa, Jacek& Grabarska, Aneta& Bielewicz, Joanna& Wlizło-Dyś, Ewa& Rejdak, Konrad. 2017. Correlation between CH2DS2-VASc Score and Serum Leptin Levels in Cardioembolic Stroke Patients: The Impact of Metabolic Syndrome. International Journal of Endocrinology،Vol. 2017, no. 2017, pp.1-10.
https://search.emarefa.net/detail/BIM-1166612

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Szczepańska-Szerej, Anna…[et al.]. Correlation between CH2DS2-VASc Score and Serum Leptin Levels in Cardioembolic Stroke Patients: The Impact of Metabolic Syndrome. International Journal of Endocrinology No. 2017 (2017), pp.1-10.
https://search.emarefa.net/detail/BIM-1166612

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Szczepańska-Szerej, Anna& Kurzepa, Jacek& Grabarska, Aneta& Bielewicz, Joanna& Wlizło-Dyś, Ewa& Rejdak, Konrad. Correlation between CH2DS2-VASc Score and Serum Leptin Levels in Cardioembolic Stroke Patients: The Impact of Metabolic Syndrome. International Journal of Endocrinology. 2017. Vol. 2017, no. 2017, pp.1-10.
https://search.emarefa.net/detail/BIM-1166612

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-1166612